Siltuximab monoclonal antibody drug. Targets interleukin-6 receptor and is approved for the treatment of rheumatoid arthritis. Generic name and styliz

---

Siltuximab monoclonal antibody drug. Targets interleukin-6 receptor and is approved for the treatment of rheumatoid arthritis. Generic name and stylized antibody.

---

Size: 9000px × 5098px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: angiofollicular, antibody, arthritis, biological, biosimilar, biotech, biotechnology, cancer, castleman, chimeric, cytokine, disease, drug, giant, hamartoma, hyperplasia, il-6, immunoglobulin, immunology, infusion, injection, inn, interleukin, interleukin-6, lymph, lymphoid, lymphoproliferative, mab, macrophage, mcd, monoclonal, multicentric, muscle, myokine, node, nomenclature, peptide, prostate, protein, renal, rheumatoid, siltuximab